vs
Aterian, Inc.（ATER）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是Aterian, Inc.的1.3倍（$19.6M vs $15.1M），Aterian, Inc.净利率更高（-52.5% vs -177.4%，领先124.9%），STANDARD BIOTOOLS INC.同比增速更快（-11.5% vs -38.5%），Aterian, Inc.自由现金流更多（$-1.0M vs $-23.1M），过去两年STANDARD BIOTOOLS INC.的营收复合增速更高（-12.2% vs -13.5%）
Aterian, Inc.是一家技术驱动的消费品企业，依托人工智能与数据分析挖掘市场需求，开发、采购并销售家居、个护、健康、户外、宠物用品等多品类高性价比商品，主要通过全球主流电商平台销往北美、欧洲等核心市场。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
ATER vs LAB — 直观对比
营收规模更大
LAB
是对方的1.3倍
$15.1M
营收增速更快
LAB
高出27.0%
-38.5%
净利率更高
ATER
高出124.9%
-177.4%
自由现金流更多
ATER
多$22.0M
$-23.1M
两年增速更快
LAB
近两年复合增速
-13.5%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $15.1M | $19.6M |
| 净利润 | $-7.9M | $-34.7M |
| 毛利率 | 56.1% | 48.5% |
| 营业利润率 | -51.1% | -168.5% |
| 净利率 | -52.5% | -177.4% |
| 营收同比 | -38.5% | -11.5% |
| 净利润同比 | -512.2% | -28.8% |
| 每股收益（稀释后） | — | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATERLAB
| Q4 25 | $15.1M | — | ||
| Q3 25 | $19.0M | $19.6M | ||
| Q2 25 | $19.5M | $21.8M | ||
| Q1 25 | $15.4M | $40.8M | ||
| Q4 24 | $24.6M | — | ||
| Q3 24 | $26.2M | $22.1M | ||
| Q2 24 | $28.0M | $22.5M | ||
| Q1 24 | $20.2M | $45.5M |
净利润ATERLAB
| Q4 25 | $-7.9M | — | ||
| Q3 25 | $-2.3M | $-34.7M | ||
| Q2 25 | $-4.9M | $-33.5M | ||
| Q1 25 | $-3.9M | $-26.0M | ||
| Q4 24 | $-1.3M | — | ||
| Q3 24 | $-1.8M | $-26.9M | ||
| Q2 24 | $-3.6M | $-45.7M | ||
| Q1 24 | $-5.2M | $-32.2M |
毛利率ATERLAB
| Q4 25 | 56.1% | — | ||
| Q3 25 | 56.1% | 48.5% | ||
| Q2 25 | 54.3% | 48.8% | ||
| Q1 25 | 61.4% | 48.4% | ||
| Q4 24 | 63.4% | — | ||
| Q3 24 | 60.3% | 54.9% | ||
| Q2 24 | 60.4% | 46.1% | ||
| Q1 24 | 65.1% | 53.1% |
营业利润率ATERLAB
| Q4 25 | -51.1% | — | ||
| Q3 25 | -10.7% | -168.5% | ||
| Q2 25 | -23.1% | -118.1% | ||
| Q1 25 | -24.1% | -80.8% | ||
| Q4 24 | -6.5% | — | ||
| Q3 24 | -6.6% | -120.9% | ||
| Q2 24 | -11.5% | -134.5% | ||
| Q1 24 | -26.1% | -132.2% |
净利率ATERLAB
| Q4 25 | -52.5% | — | ||
| Q3 25 | -12.0% | -177.4% | ||
| Q2 25 | -25.0% | -153.7% | ||
| Q1 25 | -25.4% | -63.8% | ||
| Q4 24 | -5.3% | — | ||
| Q3 24 | -6.8% | -122.0% | ||
| Q2 24 | -13.0% | -203.3% | ||
| Q1 24 | -25.5% | -70.6% |
每股收益（稀释后）ATERLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.09 | ||
| Q2 25 | — | $-0.09 | ||
| Q1 25 | — | $-0.07 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-0.07 | ||
| Q2 24 | — | $-0.12 | ||
| Q1 24 | — | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.9M | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $15.2M | $399.7M |
| 总资产 | $29.6M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATERLAB
| Q4 25 | $4.9M | — | ||
| Q3 25 | $7.6M | $129.4M | ||
| Q2 25 | $10.5M | $158.6M | ||
| Q1 25 | $14.3M | $150.9M | ||
| Q4 24 | $18.0M | — | ||
| Q3 24 | $16.1M | $210.6M | ||
| Q2 24 | $20.3M | $269.8M | ||
| Q1 24 | $17.5M | $287.1M |
总债务ATERLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益ATERLAB
| Q4 25 | $15.2M | — | ||
| Q3 25 | $22.6M | $399.7M | ||
| Q2 25 | $24.3M | $424.5M | ||
| Q1 25 | $27.0M | $454.6M | ||
| Q4 24 | $30.0M | — | ||
| Q3 24 | $30.6M | $489.3M | ||
| Q2 24 | $30.9M | $510.3M | ||
| Q1 24 | $33.0M | $577.3M |
总资产ATERLAB
| Q4 25 | $29.6M | — | ||
| Q3 25 | $40.1M | $539.6M | ||
| Q2 25 | $45.4M | $557.0M | ||
| Q1 25 | $49.8M | $579.6M | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $52.1M | $681.5M | ||
| Q2 24 | $59.9M | $708.7M | ||
| Q1 24 | $55.7M | $777.7M |
负债/权益比ATERLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.0M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $-1.0M | $-23.1M |
| 自由现金流率自由现金流/营收 | -6.9% | -118.1% |
| 资本支出强度资本支出/营收 | 0.0% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势，按日历期对齐
经营现金流ATERLAB
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-1.6M | $-22.2M | ||
| Q2 25 | $-4.4M | $-20.7M | ||
| Q1 25 | $-3.9M | $-30.3M | ||
| Q4 24 | $-9.0K | — | ||
| Q3 24 | $-722.0K | $-27.9M | ||
| Q2 24 | $2.9M | $-39.0M | ||
| Q1 24 | $-6.0K | $-62.5M |
自由现金流ATERLAB
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-1.6M | $-23.1M | ||
| Q2 25 | $-4.4M | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | $2.9M | $-41.0M | ||
| Q1 24 | $-42.0K | $-63.3M |
自由现金流率ATERLAB
| Q4 25 | -6.9% | — | ||
| Q3 25 | -8.4% | -118.1% | ||
| Q2 25 | -22.7% | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | 10.3% | -182.2% | ||
| Q1 24 | -0.2% | -138.9% |
资本支出强度ATERLAB
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.2% | 4.5% | ||
| Q2 25 | 0.0% | 8.7% | ||
| Q1 25 | 0.0% | 12.4% | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | 10.2% | ||
| Q2 24 | 0.0% | 8.6% | ||
| Q1 24 | 0.2% | 1.7% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATER
| Sales Channel Directly To Consumer | $13.1M | 87% |
| Heating Cooling And Air Quality | $2.1M | 14% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
